US firm SAFC plans to turn its dry powder culture media manufacturing plant in Lenexa, Kansas into a “centre of excellence” with $6.3m (€4.7m) capacity expansion.
US drug packaging firm Comar says acquisition of Universal Container Corp (Unicon) provides capacity for growth, particularly in key liquid medication delivery device market.
Baxter’s BioPharma Solutions unit has expanded its manufacturing facility in Halle, Germany, adding capacity to meet clients’ demand for large-scale production of cytotoxics.
The Klockner Pentaplast Group has invested $37m (€27m) to expand PVC production capacity and add shrink-label film capabilities at its facilities in Thailand and the US.
The Botswanan government is seeking to initiate local pharma manufacturing, which would lower drug prices, by entering into public-private partnerships (PPP), according to a report by F&S.
Revenues fell 3 per cent in 2009 at SAFC but pharmaceutical sector demand for vaccine manufacturing products helped firm finish year with six months of growth.
Genzyme is outsourcing fill and finish manufacturing of several major drugs to Hospira in response to in-house difficulties at its Allston Landing facility in Boston, Massachusetts, US.
The American Peptide Company (APC) plans to set up an R&D unit at its facility in Sunnydale, California to better serve growing demand for innovative technologies.
Canadian biologics CMO BioVectra has been contracted to make trial supplies of the candidate cancer treatment Prolanta by US biopharmaceutical firm Oncolix.
The FDA has issued an import alert against products manufactured at two Apotex facilities after the agency issued a warning letter, which raised several issues that the company is now working to resolve.
Biotech processes will be improved by using Sani-Tech Ultra tubing, according to its manufacturer that claims the product has a longer lifespan and lower concentration of extractables than its competitors.
Ireland’s API manufacturing sector suffered a blow on Friday with Corden Pharmachem’s announcement that it is phasing-out manufacturing at its facility in Little Island, Cork.
At BIO 2009 Symyx was promoting its new CDMO offering, which it believes meets a “real need in the industry” and can save clients time and materials by leveraging its prior knowledge.
Freeman Technologies, which showcased its FT4 Rheometer at Achema in Frankfurt, Germany, last week, says pharmaceutical powders are complex systems that require analysis of multiple parameters.
Althea Technologies’ biologics and injectables contract development, manufacturing and testing facility in San Diego, US is open for business, bringing to an end the firm’s two year campaign to expand capacity.
Novozymes and Millipore have launched an animal-free culture supplement, which has been designed to reduce risk and regulatory pressures in upstream biopharmaceutical processes.
India’s Shasun Chemicals officially closed its pharmaceutical manufacturing plant near Annan in Scotland today yesterday, a little under six months after saying that it was ‘underused’ and could not be kept on as a going concern
ESS Technologies’ says its unique robotic loading system improves the speed, efficiency and accuracy of pharmaceutical manufacturers’ tube filling and closing operations.
Borealis is launching a new cast film that it claims offers best-in-class transparency, high purity and can be tailored to a client’s needs, making it ideal for packaging manufacturers needing clear coverings.
Industrial manufacturing specialist Honeywell has been contracted to manage and control production processes at the newly constructed US operations of UK biotechnology company Shire.
Indian process technology firm ACE Technologies has won the contract to sell and service GEA Pharma Systems’ range of Courtoy tablet presses to local drug manufacturers as part of the latter company’s Asian expansion plan.
Valois Pharma is installing precision plastic molding capabilities at its manufacturing facility in Congers, New York, US as part of ongoing efforts to modernise its global manufacturing operations.
Thermo Fisher Scientific hopes that the web functionality offered by the latest generation of its Darwin LIMS system will help it become the natural selection for drug makers seeking an all-in-one QA solution.
Lonza is spending $26m to expand capacity at its facility in Walkersville, Maryland, US as regulatory progress made with Osiris’ Prochymal looks set to kick start the era of cell therapies.
As 2008 drew to a close and people the world over welcomed the New Year, few would have noticed the passing of Europe’s paracetamol industry as Rhodia closed the doors of the region’s last manufacturing facility in Roussillon, southern France.
Schott plans to add two giant glass melting tanks at its facility in Mainz, Germany, continuing the expansion of pharmaceutical tubing production capacity and creating 135 new jobs in the process.
The timely identification of contaminants in pharmaceutical manufacture can be critical to avoiding costly delays. While it is relatively straightforward to establish the composition of a contaminating particle, determining its origin in the manufacturing...
One of Actavis’ Bulgarian production facilities is being bought out by the management, which will provide contract manufacturing services to the generic maker and other companies.
Final guidance on the cooperative manufacture of licensed biologics has been issued by the FDA, which gives companies an outline of how to share responsibilities through the production process.
Merck Serono has begun work on the expansion of its Swiss biotech facility, with the additional capacity being used to meet rising demand for Erbitux (cetuximab).
The US Food and Drug Administration (FDA) has issued a warning letter to Pharmalucence for alleged deviations from current good manufacturing practices (cGMP).
India’s Shasun Pharma Solutions is to close its manufacturing facility in Annan, Scotland explaining that the site is being “underused,” according to media reports.
GE Healthcare’s range of AxiChrom columns will simplify manufacturing operations, improve reproducibility and allow for faster change over according to company senior product manager, Per Karlberg.
in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from Malvern, Caen, Finesse and Bausch.
Takeda Pharmaceutical has filed a lawsuit in an attempt to recoup $26.7m in damages, after it had to recall a product made by a contract manufacturing organisation (CMO).
Sandoz Canada, a unit of Novartis’ generics arm, has opened a second manufacturing plant at its site in Boucherville, Quebec, boosting local production capacity 66 per cent.
in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from Genevac, Lock and AdvantaPure.
Sancilio & Co (SCI) says that its new contract manufacturing plant in Riviera Beach, Florida can provide pharmaceutical manufacturers with small batch production capacity for drug tablets and capsules.
in-PharmaTechnologist.com’s periodic round-up of employment developments in the pharmaceutical manufacturing industry includes news on Abbott, Pfizer, Gilead and Clarcor.
San Antonio-headquartered manufacturing firm DPT Laboratories has won a long-term contract to produce stocks of CPEX Pharmaceuticals’ candidate intranasal insulin product Nasulin for clinical trials.
IndiaSoft Technologies, which is headquartered in the city of Pune
in Maharashtra state has won the contract to distribute Performance
Fluid Dynamics' (PFD) DynoChem productivity software to drug
manufacturers in the region.
US technology specialist Honeywell International says that new
features of its POMSnet manufacturing execution system (MES) can
help pharmaceutical firms reduce production errors.
Continued weakness in the market for products used in the
manufacture of biologic drugs was the main reason why Millipore
experienced a 'challenging' quarter, according to CEO Martin
Madaus.
